Amgen Halts Construction On Manufacturing Plant In Ireland
This article was originally published in The Pink Sheet Daily
Executive Summary
The planned multi-product facility would have manufactured “drugs in the pipeline,” Amgen tells “The Pink Sheet” DAILY.
You may also be interested in...
Amgen Says 2007 Profits Will Top October Projections
California biotech cites cost-cutting measures as reason for upgraded earnings per share guidance of $4.30.
Amgen Says 2007 Profits Will Top October Projections
California biotech cites cost-cutting measures as reason for upgraded earnings per share guidance of $4.30.
Amgen Restructures Amid Anemic Aranesp Sales
Biotech will eliminate up to 2,600 jobs, prioritize R&D spend to achieve $1 billion to $1.3 billion in pre-tax savings.